Gökhan Öztürk

5PUBLICATIONS
60CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Immunosuppressive Tumor Microenvironment Signatures Predict Early Progression in NSCLC Patients Receiving Immune Checkpoint Inhibitors: A Transcriptomic and Immune Deconvolution Analysis of GSE135222.

|Jun 26, 2026
Longitudinal Changes in Body Composition and Fluid Distribution During Chemotherapy in Breast Cancer Patients: A Prospective Single-Center Longitudinal Observational Study Using Bioimpedance Spectroscopy.

|Feb 11, 2026
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.

Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu

|Jan 28, 2026
Integration of the GRIm Score with Pathologic Immune and Stromal Markers to Develop a Combined Prognostic Model in Gastric Cancer: A Retrospective Single-Center Study.

Gökhan Öztürk, Ebru Taştekin, Canberk Topuz

|May 07, 2025
Cabozantinib-Associated Posterior Reversible Encephalopathy Syndrome

Gökhan Öztürk, Aysun Fatma Akkuş, Muhammet Bekir Hacıoğlu

Pageof 1

Frequent Collaborators

3 joint publications

Aysun Fatma Akkuş

3 joint publications

Muhammet Bekir Hacıoğlu

2 joint publications

Tayyip İlker Aydın

2 joint publications

Sernaz Topaloğlu